modifications to glutathione Apoptosis and glutathione: beyond an antioxidant The Glutathione System: A Journey

While pharmacological treatments and phytochemicals could provide symptomatic relief and neuroprotective effects, their efficacy is hindered by poor bioavailability, systemic side effects, and restricted BBB penetration

USF1 and USF2, but not c-Myc, can bind to this E-box and overexpression of either one can inhibit the promoter activity (Cheng et al., 2005)

These systems use both the enhanced cellular uptake properties of AuNPs and their potential to cross the blood-brain barrier (BBB) when surface-functionalized with targeting peptides

[accessed 11 Jul 22] Health Service Executive (HSE) (2008) Quality and patient safety directorate